Status:
COMPLETED
Effectiveness of Locally Delivered Morus Alba Gel on Moderate Periodontitis
Lead Sponsor:
KLE VK Institute of Dental Sciences
Conditions:
Chronic Periodontitis
Eligibility:
All Genders
35-55 years
Phase:
NA
Brief Summary
Background: Periodontitis is a chronic inflammatory disease of tooth and supporting tissues with clinical signs of bone and connective tissue loss and is mediated by a combination of periodontal patho...
Detailed Description
Morus alba is invaluable member of the plant kingdom belonging to the family Moraceae and the genus Morus. It is extensively cultivated for leaf yield in sericulture. Morus alba have long been used in...
Eligibility Criteria
Inclusion
- 35 to 55 years old
- untreated moderate chronic periodontitis having probing pocket depth of ≥5 mm in atleast two different teeth
Exclusion
- use of antibiotics or anti-inflammatory drugs during the last 6 months before baseline examination
- Received periodontal treatment in the last 6 months
- pregnant or lactating
- allergy to chlorhexidine or any of the components in the tested products
- using tobacco products in any form
- systemic diseases (e.g., diabetes mellitus, hypertension and immunological disorders)
- ) orthodontic treatment
- alcoholics
- removable prostheses
- Healthy with a normal BMI
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03475394
Start Date
January 1 2015
End Date
November 1 2015
Last Update
October 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.